Skip to content
Boost Up Blog – Lifestyle
Author:
UCB
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
August 5, 2026
T3 Defense Inc. Subsidiaries Rimon and Tiltan Deliver Strong Year-to-Date Operating Performance
August 4, 2026
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
July 8, 2026
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
June 17, 2026
Nimbus Launches Live Red Team Drone Threat Emulation, Deploying Weaponized FPV Systems to Train Forces and Counter-Drone Solutions
June 16, 2026
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members
June 1, 2026